Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-24-007642
Filing Date
2024-05-09
Accepted
2024-05-09 16:56:57
Documents
64
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q gpcr-20240331x10q.htm   iXBRL 10-Q 2167436
2 EX-10.1 gpcr-20240331xex10d1.htm EX-10.1 233569
3 EX-10.2 gpcr-20240331xex10d2.htm EX-10.2 23448
4 EX-31.1 gpcr-20240331xex31d1.htm EX-31.1 16243
5 EX-31.2 gpcr-20240331xex31d2.htm EX-31.2 16899
6 EX-32.1 gpcr-20240331xex32d1.htm EX-32.1 9943
7 EX-32.2 gpcr-20240331xex32d2.htm EX-32.2 10230
8 GRAPHIC gpcr-20240331x10q001.jpg GRAPHIC 51111
  Complete submission text file 0001558370-24-007642.txt   8146288

Data Files

Seq Description Document Type Size
9 EX-101.SCH gpcr-20240331.xsd EX-101.SCH 45186
10 EX-101.CAL gpcr-20240331_cal.xml EX-101.CAL 46084
11 EX-101.DEF gpcr-20240331_def.xml EX-101.DEF 196381
12 EX-101.LAB gpcr-20240331_lab.xml EX-101.LAB 439269
13 EX-101.PRE gpcr-20240331_pre.xml EX-101.PRE 334787
68 EXTRACTED XBRL INSTANCE DOCUMENT gpcr-20240331x10q_htm.xml XML 1234219
Mailing Address 611 GATEWAY BLVD SUITE 223 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD SUITE 223 SOUTH SAN FRANCISCO CA 94080 (628) 229-9277
Structure Therapeutics Inc. (Filer) CIK: 0001888886 (see all company filings)

EIN.: 981480821 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41608 | Film No.: 24931641
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)